USC/Norris Comprehensive Cancer Center/Investigational Drug Services is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
USC/Norris Comprehensive Cancer Center/Investigational Drug Services has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Neoplasms.
Sponsors: Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
USC/Norris Comprehensive Cancer Center/Investigational Drug Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
USC/Norris Comprehensive Cancer Center/Investigational Drug Services has 2 clinical trials on record, with 1 currently active. Their work covers Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Neoplasms.
USC/Norris Comprehensive Cancer Center/Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.